Trials / Sponsors / European Group for Research In Schizophrenia
European Group for Research In Schizophrenia
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of T Schizophrenia; Psychosis, Cognitive Impairment | Phase 3 | 2026-01-14 |